Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.07
Delayed Data
As of Feb 11
 -0.11 / -5.05%
Today’s Change
1.90
Today|||52-Week Range
12.75
-37.27%
Year-to-Date
No recent news for Cancer Genetics Inc.

Today’s Trading

Previous close2.18
Today’s open2.17
Day’s range2.05 - 2.22
Volume49,176
Average volume (3 months)171,667
Market cap$23.2M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+50.55%
Earnings growth (this year)-13.45%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+54.30%
P/E ratioNM
Price/Sales6.20
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
APHBAmpliPhi Biosciences...-0.14-3.95%
TROVUTrovagene Inc0.000.00%
GBSNGreat Basin Scientif...-0.01-3.43%
GALTGalectin Therapeutic...+0.01+0.89%
Data as of 02/11/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$10.2M
Annual profit (last year)-$16.6M
Net profit margin-163.18%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Vice President-
Operations
Robert Fannon
Corporate headquarters
Rutherford, New Jersey

Forecasts

Partner Offers